These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26582492)

  • 1. Mode of detection: an independent prognostic factor for women with breast cancer.
    Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
    J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
    Biesheuvel C; Czene K; Orgeás CC; Hall P
    Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent prognostic value of screen detection in invasive breast cancer.
    Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
    J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
    Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
    Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
    Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
    Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
    Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
    Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
    O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
    Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
    Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
    Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
    Moshina N; Backmann HA; Skaane P; Hofvind S
    Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
    Defossez G; Quillet A; Ingrand P
    BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-related factors and prognosis in breast cancer detected by screening.
    Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
    Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast density and breast cancer-specific survival by detection mode.
    van der Waal D; Verbeek ALM; Broeders MJM
    BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.